These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38486042)

  • 1. METTL3 and METTL14-mediated N
    Wu X; Zeng M; Wei Y; Lu R; Huang Z; Huang L; Huang Y; Lu Y; Li W; Wei H; Pu J
    Sci Rep; 2024 Mar; 14(1):6155. PubMed ID: 38486042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m
    Dai YZ; Liu YD; Li J; Chen MT; Huang M; Wang F; Yang QS; Yuan JH; Sun SH
    Cell Mol Biol Lett; 2022 May; 27(1):41. PubMed ID: 35596159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N
    Liu J; Zhang N; Zeng J; Wang T; Shen Y; Ma C; Yang M
    Clin Transl Med; 2022 Nov; 12(11):e1107. PubMed ID: 36354136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m
    Chen YT; Xiang D; Zhao XY; Chu XY
    Hum Cell; 2021 Nov; 34(6):1800-1811. PubMed ID: 34374933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA m
    Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
    EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of DNA repair gene program by Hippo/YAP1-TET1 axis mediates sorafenib resistance in HCC.
    Mo C; You W; Rao Y; Lin Z; Wang S; He T; Shen H; Li X; Zhang R; Li B
    Cell Mol Life Sci; 2024 Jul; 81(1):284. PubMed ID: 38967794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SREBF2-STARD4 axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis.
    Yue X; Kong Y; Zhang Y; Sun M; Liu S; Wu Z; Gao L; Liang X; Ma C
    Cancer Sci; 2023 Feb; 114(2):477-489. PubMed ID: 35642354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Tan C; Huang Y; Huang Z; Ning Y; Huang L; Wu X; Lu Y; Wei H; Pu J
    J Hepatocell Carcinoma; 2023; 10():1479-1495. PubMed ID: 37701563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long intergenic non-protein coding RNA 1273 confers sorafenib resistance in hepatocellular carcinoma via regulation of methyltransferase 3.
    Kong H; Sun J; Zhang W; Zhang H; Li H
    Bioengineered; 2022 Feb; 13(2):3108-3121. PubMed ID: 35037556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of lncRNA PTOV1-AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR-505.
    Chi X; Chen Z; Chen Y; Hong H; Yu J; Lv L
    J Biochem Mol Toxicol; 2023 Oct; 37(10):e23437. PubMed ID: 37352125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1.
    Zhou Y; Huang Y; Dai T; Hua Z; Xu J; Lin Y; Han L; Yue X; Ho L; Lu J; Ai X
    Biomed Pharmacother; 2021 Jan; 133():111030. PubMed ID: 33378944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA URB1-Antisense RNA 1 (AS1) Suppresses Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving Ferritin Phase Separation.
    Gao Y; Tong M; Wong TL; Ng KY; Xie YN; Wang Z; Yu H; Loh JJ; Li M; Ma S
    ACS Nano; 2023 Nov; 17(22):22240-22258. PubMed ID: 37966480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma.
    Sui C; Dong Z; Yang C; Zhang M; Dai B; Geng L; Lu J; Yang J; Xu M
    J Cell Mol Med; 2019 Sep; 23(9):6024-6033. PubMed ID: 31210410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.
    Zhang X; Su T; Wu Y; Cai Y; Wang L; Liang C; Zhou L; Wang S; Li XX; Peng S; Kuang M; Yu J; Xu L
    Cancer Res; 2024 Mar; 84(6):827-840. PubMed ID: 38241695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N
    Wei H; Huang L; Lu Q; Huang Z; Huang Y; Xu Z; Li W; Pu J
    J Hepatocell Carcinoma; 2023; 10():1991-2007. PubMed ID: 37954496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m
    Bo C; Li N; He L; Zhang S; An Y
    Hum Cell; 2021 Nov; 34(6):1843-1854. PubMed ID: 34491544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Xu J; Wan Z; Tang M; Lin Z; Jiang S; Ji L; Gorshkov K; Mao Q; Xia S; Cen D; Zheng J; Liang X; Cai X
    Mol Cancer; 2020 Nov; 19(1):163. PubMed ID: 33222692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.